# Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

> **NCT03531320** · PHASE1,PHASE2 · COMPLETED · sponsor: **InnoPharmax Inc.** · enrollment: 19 (actual)

## Conditions studied

- Gastrointestinal Cancer
- Biliary Tract Cancer

## Interventions

- **DRUG:** D07001-softgel capsules

## Key facts

- **NCT ID:** NCT03531320
- **Lead sponsor:** InnoPharmax Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2020-12-28
- **Final completion:** 2020-12-29
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03531320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03531320, "Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03531320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*